1,3-bis((3,5-bis(trifluoromethyl)phenyl)sulfonyl)-1,3-dihydro-2H-imidazol-2-one

ID: ALA4444236

Chembl Id: CHEMBL4444236

PubChem CID: 155517204

Max Phase: Preclinical

Molecular Formula: C19H8F12N2O5S2

Molecular Weight: 636.39

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  O=c1n(S(=O)(=O)c2cc(C(F)(F)F)cc(C(F)(F)F)c2)ccn1S(=O)(=O)c1cc(C(F)(F)F)cc(C(F)(F)F)c1

Standard InChI:  InChI=1S/C19H8F12N2O5S2/c20-16(21,22)9-3-10(17(23,24)25)6-13(5-9)39(35,36)32-1-2-33(15(32)34)40(37,38)14-7-11(18(26,27)28)4-12(8-14)19(29,30)31/h1-8H

Standard InChI Key:  LKQXJWVEXOZCLC-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4444236

    ---

Associated Targets(Human)

A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HuCC-A1 (92 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MOLT-3 (638 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MRC5 (9203 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 636.39Molecular Weight (Monoisotopic): 635.9683AlogP: 5.20#Rotatable Bonds: 4
Polar Surface Area: 95.21Molecular Species: HBA: 7HBD:
#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): #RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: CX LogP: 5.98CX LogD: 5.98
Aromatic Rings: 3Heavy Atoms: 40QED Weighted: 0.37Np Likeness Score: -0.63

References

1. Sittihan S, Jumpathong W, Sopha P, Ruchirawat S..  (2020)  Synthesis and antitumor activity of bis(arylsulfonyl)dihydroimidazolinone derivatives.,  30  (1): [PMID:31704206] [10.1016/j.bmcl.2019.126776]

Source